These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34525838)

  • 1. Baseline Characteristics of Patients With Cavernous Angiomas With Symptomatic Hemorrhage in Multisite Trial Readiness Project.
    Kim H; Flemming KD; Nelson JA; Lui A; Majersik JJ; Cruz MD; Zabramski J; Trevizo O; Lanzino G; Zafar A; Torbey M; Mabray MC; Robinson M; Narvid J; Lupo J; Thompson RE; Hanley DF; McBee N; Treine K; Ostapkovich N; Stadnik A; Piedad K; Hobson N; Carroll T; Shkoukani A; Carrión-Penagos J; Mendoza-Puccini C; Koenig JI; Awad I
    Stroke; 2021 Dec; 52(12):3829-3838. PubMed ID: 34525838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial Readiness in Cavernous Angiomas With Symptomatic Hemorrhage (CASH).
    Polster SP; Cao Y; Carroll T; Flemming K; Girard R; Hanley D; Hobson N; Kim H; Koenig J; Koskimäki J; Lane K; Majersik JJ; McBee N; Morrison L; Shenkar R; Stadnik A; Thompson RE; Zabramski J; Zeineddine HA; Awad IA
    Neurosurgery; 2019 Apr; 84(4):954-964. PubMed ID: 29660039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part I: Event Rates and Clinical Outcome.
    Flemming KD; Kim H; Hage S; Mandrekar J; Kinkade S; Girard R; Torbey M; Huang J; Huston J; Shu Y; Lanzino G; Selwyn R; Hart B; Mabray M; Feghali J; Sair HI; Narvid J; Lupo JM; Lee J; Stadnik A; Alcazar-Felix RJ; Shenkar R; Lane K; McBee N; Treine K; Ostapkovich N; Wang Y; Thompson R; Koenig JI; Carroll T; Hanley D; Awad I
    Stroke; 2024 Jan; 55(1):22-30. PubMed ID: 38134268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling.
    Hage S; Kinkade S; Girard R; Flemming KD; Kim H; Torbey MT; Huang J; Huston J; Shu Y; Selwyn RG; Hart BL; Mabray MC; Feghali J; Sair HI; Narvid J; Lupo JM; Lee J; Stadnik A; Alcazar-Felix RJ; Shenkar R; Hobson N; DeBiasse D; Lane K; McBee NA; Treine K; Ostapkovich N; Wang Y; Thompson RE; Koenig JI; Carroll T; Hanley DF; Awad IA
    Stroke; 2024 Jan; 55(1):31-39. PubMed ID: 38134265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage.
    Zeineddine HA; Girard R; Cao Y; Hobson N; Fam MD; Stadnik A; Tan H; Shen J; Chaudagar K; Shenkar R; Thompson RE; McBee N; Hanley D; Carroll T; Christoforidis GA; Awad IA
    J Magn Reson Imaging; 2018 Apr; 47(4):1133-1138. PubMed ID: 28791783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH).
    Girard R; Li Y; Stadnik A; Shenkar R; Hobson N; Romanos S; Srinath A; Moore T; Lightle R; Shkoukani A; Akers A; Carroll T; Christoforidis GA; Koenig JI; Lee C; Piedad K; Greenberg SM; Kim H; Flemming KD; Ji Y; Awad IA
    Neurosurgery; 2021 Feb; 88(3):686-697. PubMed ID: 33469662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical imaging changes in cerebral cavernous angiomas during prospective surveillance.
    Carrión-Penagos J; Zeineddine HA; Polster SP; Girard R; Lyne SB; Koskimäki J; Romanos S; Srinath A; Zhang D; Cao Y; Stadnik A; Piedad K; Shenkar R; Awad IA
    J Neurosurg; 2021 Mar; 134(3):1147-1154. PubMed ID: 32244216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations.
    Girard R; Fam MD; Zeineddine HA; Tan H; Mikati AG; Shi C; Jesselson M; Shenkar R; Wu M; Cao Y; Hobson N; Larsson HBW; Christoforidis GA; Awad IA
    J Neurosurg; 2017 Jul; 127(1):102-110. PubMed ID: 27494817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial.
    Polster SP; Stadnik A; Akers AL; Cao Y; Christoforidis GA; Fam MD; Flemming KD; Girard R; Hobson N; Koenig JI; Koskimäki J; Lane K; Liao JK; Lee C; Lyne SB; McBee N; Morrison L; Piedad K; Shenkar R; Sorrentino M; Thompson RE; Whitehead KJ; Zeineddine HA; Hanley DF; Awad IA
    Neurosurgery; 2019 Dec; 85(6):843-853. PubMed ID: 30476251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical course of untreated thalamic cavernous malformations: hemorrhage risk and neurological outcomes.
    Tian KB; Zheng JJ; Ma JP; Hao SY; Wang L; Zhang LW; Wu Z; Zhang JT; Li D
    J Neurosurg; 2017 Sep; 127(3):480-491. PubMed ID: 27834594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical presentation, hemorrhage risk, and outcome in patients with familial cavernous malformations: a pragmatic prospective analysis of 75 patients.
    Alalfi MO; Lanzino G; Flemming KD
    J Neurosurg; 2023 Oct; 139(4):1018-1024. PubMed ID: 36933254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cavernous Angioma Symptomatic Hemorrhage (CASH) Trial Readiness II: Imaging Biomarkers and Trial Modeling.
    Hage S; Kinkade S; Girard R; Flemming KD; Kim H; Torbey MT; Huang J; Huston J; Shu Y; Selwyn RG; Hart BL; Mabray MC; Feghali J; Sair HI; Narvid J; Lupo JM; Lee J; Stadnik A; Alcazar R; Shenkar R; Hobson N; DeBiasse D; Lane K; McBee N; Treine K; Ostapkovich N; Wang Y; Thompson RE; Mendoza-Puccini C; Koenig J; Carroll T; Hanley DF; Awad IA
    medRxiv; 2023 Jun; ():. PubMed ID: 37333396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation.
    Choquet H; Nelson J; Pawlikowska L; McCulloch CE; Akers A; Baca B; Khan Y; Hart B; Morrison L; Kim H
    Cerebrovasc Dis; 2014; 37(1):57-63. PubMed ID: 24401931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorrhage owing to cerebral cavernous malformation: imaging, clinical, and histopathological considerations.
    Kurihara N; Suzuki H; Kato Y; Rikimaru H; Sato A; Uenohara H
    Jpn J Radiol; 2020 Jul; 38(7):613-621. PubMed ID: 32221793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracranial Hemorrhage Rate and Lesion Burden in Patients With Familial Cerebral Cavernous Malformation.
    Weinsheimer S; Nelson J; Abla AA; Ko NU; Tsang C; Okoye O; Zabramski JM; Akers A; Zafar A; Mabray MC; Hart BL; Morrison L; McCulloch CE; Kim H;
    J Am Heart Assoc; 2023 Feb; 12(3):e027572. PubMed ID: 36695309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfusion and permeability as diagnostic biomarkers of cavernous angioma with symptomatic hemorrhage.
    Sone JY; Li Y; Hobson N; Romanos SG; Srinath A; Lyne SB; Shkoukani A; Carrión-Penagos J; Stadnik A; Piedad K; Lightle R; Moore T; Li Y; Bi D; Shenkar R; Carroll T; Ji Y; Girard R; Awad IA
    J Cereb Blood Flow Metab; 2021 Nov; 41(11):2944-2956. PubMed ID: 34039038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medullary hemorrhage that preceded the onset of multiple cavernous angiomas.
    Naoi T; Nakao K; Nakamura Y; Ando A; Kawakami T
    Intern Med; 2015; 54(7):843-6. PubMed ID: 25832954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of familial cerebral cavernous malformation syndrome in children: a multicenter cohort study.
    Geraldo AF; Alves CAPF; Luis A; Tortora D; Guimarães J; Abreu D; Reimão S; Pavanello M; de Marco P; Scala M; Capra V; Vaz R; Rossi A; Schwartz ES; Mankad K; Severino M
    Neuroradiology; 2023 Feb; 65(2):401-414. PubMed ID: 36198887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity After Symptomatic Hemorrhage of Cerebral Cavernous Malformation: A Nomogram Approach to Risk Assessment.
    Ma L; Zhang S; Li Z; Wu CX; Wang Z; Zhan L; Hao Q; Wang H; Ye X; Chen X; Liu YO; Wang S; Zhao YL
    Stroke; 2020 Oct; 51(10):2997-3006. PubMed ID: 32951540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Susceptibility Mapping in Cerebral Cavernous Malformations: Clinical Correlations.
    Tan H; Zhang L; Mikati AG; Girard R; Khanna O; Fam MD; Liu T; Wang Y; Edelman RR; Christoforidis G; Awad IA
    AJNR Am J Neuroradiol; 2016 Jul; 37(7):1209-15. PubMed ID: 26965464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.